Bioactive Material Coated Stent Surface Energy Matching

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medical devices coated with bioactive materials face challenges in achieving optimal adhesion and controlled release of drugs due to adverse side effects from polymer carriers and inadequate surface energy matching between the device and the bioactive material.

Innovation Solution

The medical device features a contact surface with a defined total surface energy density, matching the polar and non-polar components of the bioactive material, achieved through techniques like selective etching, polishing, passivation, and ion beam penetration, allowing for improved adhesion and controlled release of the bioactive material.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If polymer carriers are used to adhere drugs to stents for delivery, then the drugs can be delivered into the patient, but adverse side effects occur which are undesirable for the patient

Engineering Contradiction:
Improvedrug delivery effectivenessVSAvoidadverse side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and eliminates the polymer carrier component from the drug delivery system. Instead of using polymer carriers to adhere and deliver drugs, the patent directly coats the drug onto the stent surface through surface energy matching, thereby removing the source of adverse side effects while maintaining drug delivery functionality

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces surface energy density matching as an intermediary mechanism between the stent and the drug. By matching the surface energy densities, the patent achieves effective drug adhesion and controlled release without requiring polymer carriers, thus eliminating harmful side effects

Inventive Principle:
Principle #24Intermediary (Mediator)

2Strength

If the surface energy densities of the contact surface and bioactive material are matched, then adhesion of the bioactive material is improved, but additional surface treatment steps are required

Engineering Contradiction:
Improveadhesion strengthVSAvoidsurface treatment complexity
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The invention changes the surface energy density parameter of the contact surface to match that of the bioactive material. This parameter change is achieved through controlled surface treatments that adjust the surface chemistry, enabling direct drug coating without complex multi-layer polymer systems

Inventive Principle:
Principle #35Parameter changes

3Strength

If roughened or textured surface is provided on stent, then adhesion of bioactive material is increased, but manufacturing complexity increases

Engineering Contradiction:
Improveadhesion strengthVSAvoidmanufacturing ease
Core Design Contradiction:
StrengthVSEase of manufacture

Solution Approach 1:

Instead of changing the physical topology of the surface (roughening), the invention changes the surface energy density parameter through chemical or physical surface treatments. This approach achieves enhanced adhesion while maintaining manufacturing simplicity, as the treatments can be applied to smooth surfaces without complex forming operations

Inventive Principle:
Principle #35Parameter changes

4Reliability

If porous surface with composite material is used, then bioactive agent delivery is enabled, but material complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvebioactive agent deliveryVSAvoidcomposite material complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention extracts and removes the complex porous composite material structure from the stent design. By matching surface energy densities, the patent enables direct drug coating on simpler surfaces, achieving reliable bioactive agent delivery without the need for porous structures or multi-material composites

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the bonding and elution of bioactive materials from the device, optimizing their delivery and reducing the need for additional polymer layers, while ensuring effective drug release and minimizing adverse reactions.

Implementation Method 1

achieved through techniques like selective etching, polishing, passivation, and ion beam penetration

Methodology Applied
Scientific EffectSelective etching:

Implementation Method 2

achieved through techniques like selective etching, polishing, passivation, and ion beam penetration

Methodology Applied
Scientific EffectPolishing:

Implementation Method 3

achieved through techniques like selective etching, polishing, passivation, and ion beam penetration

Methodology Applied
Scientific EffectPassivation:

Implementation Method 4

achieved through techniques like selective etching, polishing, passivation, and ion beam penetration

Methodology Applied
Scientific EffectIon beam penetration: Ion Beam

Implementation Method 5

The polar components of the surface energies are substantially matched and the dispersive (non-polar) components of the surface energies are substantially matched

Methodology Applied
Scientific EffectAdhesion: Adhesive

Implementation Method 6

enhances the bonding and elution of bioactive materials from the device

Methodology Applied
Scientific EffectElution:

Data Source

PatentEP3103487B1Bioactive material coated medical device
Publication Date: 2020.03.11 COOK MEDICAL TECHNOLOGIES LLC
  • EP3103487B1 patent drawingFigure 1~2
  • EP3103487B1 patent drawingFigure 3
  • EP3103487B1 patent drawing

AI summary

An implantable medical device includes a bioactive material coated on a contact surface. The contact surface and bioactive material each has a defined surface energy density comprising a polar component and a non-polar component. The polar components of the surface energies are substantially matched and the non-polar components of the surface energies are substantially matched so as to allow optimised bonding and elution of the material when in situ within a patient. A method for manufacturing the device is also provided.